BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9155030)

  • 1. Linker length and composition influence the flexibility of Oct-1 DNA binding.
    van Leeuwen HC; Strating MJ; Rensen M; de Laat W; van der Vliet PC
    EMBO J; 1997 Apr; 16(8):2043-53. PubMed ID: 9155030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of the POU-specific DNA-binding domain of Oct-1.
    Dekker N; Cox M; Boelens R; Verrijzer CP; van der Vliet PC; Kaptein R
    Nature; 1993 Apr; 362(6423):852-5. PubMed ID: 8479524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the Oct-3 POU-homeodomain in solution, as determined by triple resonance heteronuclear multidimensional NMR spectroscopy.
    Morita EH; Shirakawa M; Hayashi F; Imagawa M; Kyogoku Y
    Protein Sci; 1995 Apr; 4(4):729-39. PubMed ID: 7613470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The POU domain is a bipartite DNA-binding structure.
    Sturm RA; Herr W
    Nature; 1988 Dec; 336(6199):601-4. PubMed ID: 2904656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein interaction surface of the POU transcription factor UNC-86 selectively used in touch neurons.
    Röhrig S; Röckelein I; Donhauser R; Baumeister R
    EMBO J; 2000 Jul; 19(14):3694-703. PubMed ID: 10899123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The virtuoso of versatility: POU proteins that flex to fit.
    Phillips K; Luisi B
    J Mol Biol; 2000 Oct; 302(5):1023-39. PubMed ID: 11183772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization and preliminary X-ray analysis of Pit-1 POU domain complexed to a 28 base pair DNA element.
    Jacobson EM; Li P; Rosenfeld MG; Aggarwal AK
    Proteins; 1996 Feb; 24(2):263-5. PubMed ID: 8820493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The solution structure of the Oct-1 POU-specific domain reveals a striking similarity to the bacteriophage lambda repressor DNA-binding domain.
    Assa-Munt N; Mortishire-Smith RJ; Aurora R; Herr W; Wright PE
    Cell; 1993 Apr; 73(1):193-205. PubMed ID: 8462099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POU domain factors in neural development.
    Schonemann MD; Ryan AK; Erkman L; McEvilly RJ; Bermingham J; Rosenfeld MG
    Adv Exp Med Biol; 1998; 449():39-53. PubMed ID: 10026784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of phosphorylation on DNA binding properties of N Oct-3 are dictated by protein/DNA complex structures.
    Nieto L; Joseph G; Stella A; Henri P; Burlet-Schiltz O; Monsarrat B; Clottes E; Erard M
    J Mol Biol; 2007 Jul; 370(4):687-700. PubMed ID: 17543985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oct-1 enhances the in vitro replication of a mammalian autonomously replicating DNA sequence.
    Matheos DD; Ruiz MT; Price GB; Zannis-Hadjopoulos M
    J Cell Biochem; 1998 Mar; 68(3):309-27. PubMed ID: 9518258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic patterns of N Oct-3 binding to a set of neuronal promoters.
    Blaud M; Vossen C; Joseph G; Alazard R; Erard M; Nieto L
    J Mol Biol; 2004 Jun; 339(5):1049-58. PubMed ID: 15178247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oct-1 POU domain-DNA interactions: cooperative binding of isolated subdomains and effects of covalent linkage.
    Klemm JD; Pabo CO
    Genes Dev; 1996 Jan; 10(1):27-36. PubMed ID: 8557192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA binding specificity of the bipartite POU domain and its subdomains.
    Verrijzer CP; Alkema MJ; van Weperen WW; Van Leeuwen HC; Strating MJ; van der Vliet PC
    EMBO J; 1992 Dec; 11(13):4993-5003. PubMed ID: 1361172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility.
    Jacobson EM; Li P; Leon-del-Rio A; Rosenfeld MG; Aggarwal AK
    Genes Dev; 1997 Jan; 11(2):198-212. PubMed ID: 9009203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of the Oct-1 POU homeodomain determined by NMR and restrained molecular dynamics.
    Cox M; van Tilborg PJ; de Laat W; Boelens R; van Leeuwen HC; van der Vliet PC; Kaptein R
    J Biomol NMR; 1995 Jul; 6(1):23-32. PubMed ID: 7663141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for flexibility in DNA sequence recognition and VP16-induced complex formation by the Oct-1 POU domain.
    Cleary MA; Herr W
    Mol Cell Biol; 1995 Apr; 15(4):2090-100. PubMed ID: 7891704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activator recruitment by the general transcription machinery: X-ray structural analysis of the Oct-1 POU domain/human U1 octamer/SNAP190 peptide ternary complex.
    Hovde S; Hinkley CS; Strong K; Brooks A; Gu L; Henry RW; Geiger J
    Genes Dev; 2002 Nov; 16(21):2772-7. PubMed ID: 12414730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of the I gamma subdomain of the Mu end DNA-binding domain of phage Mu transposase.
    Clubb RT; Schumacher S; Mizuuchi K; Gronenborn AM; Clore GM
    J Mol Biol; 1997 Oct; 273(1):19-25. PubMed ID: 9367742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An altered-specificity mutation in a human POU domain demonstrates functional analogy between the POU-specific subdomain and phage lambda repressor.
    Jancso A; Botfield MC; Sowers LC; Weiss MA
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3887-91. PubMed ID: 8171007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.